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ABSTRACT 
We previously reported protective haplotype HLA-B*14:02-DRB1*01:02 against 
chronic Chagas disease in Bolivia. The V281L mutant allele of the 21-Hydroxylase 
gene, CYP21A2*15, is reported to be located in the Class III region of the Human 
Leukocyte Antigen region and linked to the haplotype HLA-B*14:02-DRB1*01:02. 
The mutant allele might play a primary role in the pathogenesis of chronic Chagas 
disease in the associated HLA region. We analyzed the frequency of this allele in the 
same subjects for the previous one.  The statistical analysis showed a significant 
association of the CYP21A2*15 with resistance to severe chronic Chagas disease 
(OR=0.207273; Pv = 0.0041). However, there is no significant tendency of the mutant 
gene contribution to the resistance after the elimination of the 
HLA-B*14:02-DRB1*01:02 linked mutants (OR=0.38; Pv = 0.1533). Although the 
frequency of the CYP21A2*15 was small, we found no primary contribution of this 
mutation to the protection against chronic Chagas disease. 




Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and it is 
estimated that 10 million people are infected with this parasite worldwide but mostly in 
Latin America [1].Around 10-30% of infected individuals develop chronic Chagas 
disease which involves cardiac and/or gastrointestinal complications 10-20 years post 
infection. The cardiac manifestation of chronic Chagas disease vary from mild 
symptom to heart failure, inflammation with accompanying fibrosis scattered 
throughout the myocardium results in severe heart lesions. These abnormalities can be 
detected by characteristic changes in ECG. Chronic Chagas disease can also manifest 
as megacolon due to destruction of the autonomic enteric innervations of the 
gastrointestinal system leading to loss of gastrointestinal motility [2]. 
The strong interconnection between immune and neuroendocrine systems may 
optimize the defensive response of the host, but also set the basis for an altered 
regulation of inflammation when pathogens cannot be cleared, such as in chronic 
Chagas. However, integrative immunoendocrine response in the course of Chagas 
disease remains poorly characterized at the experimental as well as in humans [3] . 
Cortisol has a crucial role in maintaining homeostasis, influencing differentiation, 
suppressing inflammation, and affecting cross-talk among the immune, nervous and 
endocrine systems [4]. Cortisol acts both through intracellular receptors and through 
poorly characterized membrane-bound receptor that are expressed in almost every cell 
of the body. They intracellularly bind to receptors either directly to specific sites in the 
DNA, thereby altering transcription, or interact with other transcription factors, such as 
NFκB, to modulate their function. Cortisol can also act directly on cellular processes, 
leading to a much more rapid production of anti-inflammatory proteins. This causes 
exaggerated responses, which have both beneficial and toxic effects [5]. 
To produce cortisol, the major glucocorticoid in human, CYP17 (P450c17, 
17α-hydroxylase/17, 20 lyase) in the endoplasmic reticulum of the zona fasciculata and 
zona reticularis converts pregnenolone to 17α-hydroxyprenenolone. 3ß-Hydroxysteroid 
dehydrogenase in the zona fasciculata utilizes 17α-hydroxypregnenolone as a substrate 
producing 17α-hydroxyprogesterone. The latter is 21-hydroxylated by CYP21A2 to 
form 11-deoxycortisol, which is converted to cortisol by CYP11B11 (P450c11, 
11ß-hydroxylase) in mitochondria [6]. 
The structural gene encoding human CYP21A2 and a pseudogene (CYP21A1P) are 
located in the Human Leukocyte Antigen (HLA), the major histocompatibility complex. 
In human chromosome 6p21.3, CYP21A2 and CYP21A1P contain 10 exons and 9 
introns covering a distance of 3 kb showing a high homology with a 98% nucleotide 
identity in the exonic sequences and a 96% in the intronic ones [6]. Deficiency by 
mutations of the 21-Hydroxylase, is the most common cause of disorders of cortisol 
biosynthesis. The degree to which each mutation in CYP21A2 compromises enzymatic 
activity correlates with the clinical severity in the Congenital Adrenal Hyperplasia, the 
most common cause of genital ambiguity [7]. A non classic 21-Hydroxylase deficiency 
is caused by a single mutation called CYP21A2*15 that is given by an amino acid 
substitution of valine with leucine (V281L) because of a nucleotide substitution (1683 
G > T) in the exon 7 [8]. And this V281L mutation is almost invariably linked to the 
HLA-B*14:02-DRB1*01:02 haplotype in studies based on Ashkenazi Jews and other 
Caucasians [9, 10, 11].  
In our previous study we reported the strong association of the Haplotype 
HLA-B*14-DRB1*01 with the resistance to chronic Chagas disease in Bolivia. 
Therefore, we perform the genetic analysis of the V281L mutation in the previous 
study subjects to see the primary contribution of the CYP21A2*15 to the chronic 
Chagas disease. 
 
SUBJECTS AND METHODS 
Subjects  
Two hundred and ninety one patients with chronic Chagas disease (136 men 
and 155 women, mean age 45 years) were recruited from: Centro Nacional de 
Enfermedades Tropicales (CENETROP) (91 men and 119 women), Hospital Primero 
de Mayo (12 men and 7 women) and from post-operative patients at the Hospital 
Universitario Japonés (HUJ) (33 men and 29 women) in Santa Cruz, Bolivia. The 
selection criteria, grouping and clinical manifestations were previously described by 
del Puerto et al 2012 [12]. Briefly, 229 seropositive Chagas outpatients in Santa Cruz, 
Bolivia, were examined by Electrocardiogram and Barium enema colon X-ray. The 
residual 62 post-operational patients from HUJ were confirmed to be Chagas 
Megacolon during admission period. 
 The experimental protocol was approved by the Institutional Ethical Review 
Committee of the Institute of Tropical Medicine, Nagasaki University, Japan (No. 
0210170018) and the Centro Nacional de Enfermedades Tropicales (CENETROP), 
Bolivia. 
Identification of the mutant allele by RFLP 
DNA extraction and handling were described by del Puerto et al. 2012 [11]. 
PCR was carried out in a total volume of 30 μl containing 1X buffer, 0.2 mM dNTPs, 
and 1 μM each primer, 0.15 units of Taq polymerase (Takara Bio INC, JPN) and 150 
ng of sample DNA. Cycling condition: 95 oC for 5 min initial denaturation, 35 cycles 
of 1min denaturation at 95 oC, 1 min annealing, at 70 oC, 1min extension at 72 oC, and 
a final extension at 72 oC for 7 min.. Primer sequence 5’ GGA CCT GTC CTT GGG 
AGA CTA C and 5’ GCC GTG TGG TGC GGT GGG GCA AGG CTA were used and 
analysis of restriction fragments were performed according Pucci L, et al, 2010 [13]. 
The RFLP technique was performed with the BsiHKAI enzyme. The reaction 
mixture was heated overnight at 65 oC according to manufacturer instruction (New 
England, BioLab® Inc). The digested product was ran on a 1.5% agarose gel stained 
with ethidium bromide and visualized by UV light. 2.3.  
Statistical analysis 
Statistical analysis was performed by Chi square and Fisher’s exact tests using 
the StatsDirect software (StatsDirect Ltd, UK) and interval confidence of 95%. 
Hardy-Weinberg Equilibrium, linkage disequilibrium (LD) and Haplotype analyses 
were calculated with PyPopWin32.0.7.0 software [14]. 
RESULTS 
Linkage 
After the detection of the mutant alleles by RFLP as shown in Figure 1, we 
observed a linkage between the CYP21A2*15 and the alleles B*1402 and DRB1*0102, 
in the subjects [12] (Table 1). Out of the 291 samples analyzed, we could obtain results 
in 285 of them, the CYP21A2*15 was present in a frequency of 5.96 % (17 out of 285) 
of the studied population (data not shown). 
Statistical analysis 
We found a statistical significant association of this V281L to Chronic Chagas 
disease (Table 2) by independent analysis by comparing the three groups: ECG+ &/or 
Megacolon+, ECG alterations+ and Megacolon+ with the Indeterminate group; (OR = 
0.207273, Pv = 0.0041), (OR = 0.141968, Pv = 0.007) and (OR = 0.222874, Pv = 
0.0118) respectively. However, in the table 3, statistical significance disappeared after 
the elimination of B*14:02-DRB1*01:02 haplotype positives from the analysis (OR = 
0.38; Pv = 0.1533).  
DISCUSSION  
 In the present study, the CYP21A2*15 was closely linked to the HLA haplotype 
B*14:02-DRB1*01:02 in Bolivia as was previously reported in other ethinic groups 15 
We also found significant linkage between the CYP21A2*15 and the other low 
frequency alleles of HLA-B or DRB1 such as B*53:05, B*40:01, B*13:09, B*49:02, 
B*51:02, B*42:01, B*15:09, B*39:02, B*35:43, B*45:01 and DRB1*03:20. Therefore, 
we could identify the subjects who were positive for CYP21A2*15 with or without the 
resistant HLA haplotype. Independent analysis of the V281L mutation by comparing 
the chronic Chagas groups to the indeterminate gave a significant result positioning the 
mutation as a protective factor. But we consider this association as a mere coincidence 
due to the strong linkage to the resistant HLA haplotype under such a low frequency of 
this mutation in the population studied (5.96 %). Therefore, we analyzed the negative 
effect of the V281L to the chronic Chagas complications after the exclusion of 
HLA-B*14-DRB1*01 haplotype positive persons as shown in Table 3. If such a 
protective role of the V281L mutation itself is real, the other patients carrying other 
neutral alleles of the HLA-DRB1 and HLA-B also should have a tendency to be free 
from those complications. Due to the low frequency of mutant allele (N=17 out of 285, 
Supplementary), we could not definitely deny the tendency. However, there was no 
significant effect of protection after the exclusion of the HLA Haplotype (Table 3). 
 This result is consistent with an immunoendocrine analysis in patients with 
progressive forms of Chronic Chagas disease where they observed normal cortisol 
levels among the studied groups (Healthy, Indeterminate, Mild to moderate cardiac, 
and Severe cardiac); whereas a progressive diminution of DHEA-s levels, the sulfate 
ester of DHEA, was found as Chagas disease severity progressed in a previous study 
[3]. Furthermore, the DHEA and testosterone therapy in T. cruzi infected rats, 
improved the effectiveness of the host’s immune response [16]. 
 The 21-Hydroxylase encoded by the CYP21A2 gene plays an important role in 
the metabolic pathway for the conversion of cholesterol to cortisol while DHEA 
derived from Cholesterol through the conversion of the pregnenolone to 
17α-Hydroxypregnenolone by the CYP17A1 enzyme, coded in the CYP-17 gene. This 
CYP17A1 gene is located on the chromosome 10 and is independent from CYP21A2 
gene on the chromosome 6. Our observation that the functional mutant allele of 
CYP21A2 did not show any significant effect on the progression of chronic Chagas 
disease is consistence with the DHEA association, although, we had not measured the 
cortisol and DHEA levels in our subjects.  
 In conclusion, we confirmed the Chronic Chagas disease resistant HLA 
haplotype HLA-B*14:02-DRB1*01:02 is linked to CYP21A2*15. The CYP21A2*15 
protective effect was not clarified after the exclusion of the Haplotype. 
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Figure 1 :Restriction fragment length polymorphism (RFLP) patterns of 
21-Hydoroxylase gene mutation.  
Lane 1 is DNA size marker (100bp DNA ladder). 21-Hydoroxylase gene ‘s amplicons 
after digestion with BsiHKAI restriction enzyme; lane 2,3: PCR-RFLP pattern of L 
homozygotes, 1165bp, 205bp and 88bp length PCR fragments. lane 4,5: PCR-RFLP 
pattern of L/V heterozygotes,1165bp, 995bp, 205bp, 170bp and 88bp PCR fragments. 
lane 6,7: PCR-RFLP pattern of V/V homozygotes, 995bp, 205bp, 170bp and 88bp PCR 
fragments. lane 8: No digestion. 
Figure 1.  Restriction fragment length polymorphism (RFLP) patterns of 
21-Hydoroxylase gene mutation. 






Table 1 Linkage between alleles of HLA-B and HLA-DRB1 with V281L  
 
Allele obs exp diseq norm_dij chisq Degree of  Freedom Pv 
B*14:02 14.05729 1.0885 0.01689 0.62017 167.34469 2 <0.0001 
B*14:02 3.95052 0.1719 0.00492 0.64835 86.19624 2 <0.0001 
DRB1*01:02 10 1.0825 0.01149 0.44772 79.61041 5 <0.0001 
DRB1*01:02 6 0.1624 0.00752 1 217.39518 5 <0.0001 
 
Table 2 Allele frequency of the mutant and normal CYP21A2 gene   
 




Megacolon+   
 n=68(%) n=156(%) n=75(%) n=97(%) Odds Ratio P value 
L/L & L/V 11(16.2) 6(3.8) 2(2.7) 4(4.1) 0.207a , 0.142b, 0.223c 0.0041a, 0.007b, 0.0118c 
V/V 57(83.8) 150(96.1) 73(93.3) 93(95.9)   
 
a ECG+ &/or Megacolon+ vs Indeterminate  
b ECG+ alterations vs Indeterminate  
c Megacolon+ vs Indeterminate 
Table 3 Allele frequencies of the mutant and normal CYP21A2 gene after exclusion of individuals with Haplotype B*14-DRB1*01 
 




alterations   
 n=62(%) n=155(%) n=74(%) n=97(%) Odds Ratio P value 
L/L & L/V 5(8.1) 5(3.2) 1(1.3) 4(4.1) 0.380a, 0.156b, 0.490c 0.153a, 0.092b, 0.313c 
V/V 57(91.9) 150(96.8) 73(98.6) 93(95.9)   
 
a ECG+ &/or Megacolon+ vs Indeterminate  
b ECG+ vs Indeterminate  
c Megacolon+ vs Indeterminate 
